ALPHA TEKNOVA, INC. Increase (Decrease) in Income Taxes Receivable
ALPHA TEKNOVA, INC. (TKNO) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2025-03-07
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for the quarter ending 2024-12-31 was $0.00.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for the quarter ending 2023-12-31 was $0.00.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for the quarter ending 2023-09-30 was -$22.00K, a 833.33% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for the quarter ending 2022-12-31 was -$98.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for fiscal 2024 was $0.00.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for fiscal 2023 was -$22.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for fiscal 2022 was -$1.17M.
- ALPHA TEKNOVA, INC. increase (decrease) in income taxes receivable for fiscal 2021 was -$229.00K, a 118.45% decline from fiscal 2020.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $0.00 10-K · filed 2025-03-07 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$22.00K derived: sum of 2 quarters · filed 2025-03-07 | -$22.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$22.00K 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | |||
| 2022-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$95.00K derived: sum of 2 quarters · filed 2024-03-27 | -$1.17M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.07M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | -$1.07M 10-Q · filed 2023-08-11 | |||
| 2021-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$450.00K derived: sum of 2 quarters · filed 2023-03-30 | -$52.00K derived: sum of 3 quarters · filed 2023-03-30 | -$229.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$447.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$49.00K derived: sum of 2 quarters · filed 2022-11-14 | -$226.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $221.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$177.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $1.24M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |